NK cell markers predict the efficacy of IV immunoglobulins in CIDP.
Anne K MausbergMaximilian K HeiningerGerd Meyer Zu HörsteSteffen CordesMichael FleischerFabian SzepanowskiChristoph KleinschnitzHans-Peter HartungBernd C KieseierMark StettnerPublished in: Neurology(R) neuroimmunology & neuroinflammation (2020)
This study provides Class I evidence that NK cell markers predict clinical response to IVIg in patients with CIDP.
Keyphrases